Recent Posts
- doceree
- CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD
- Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani
- Utility of ctDNA in CAR-T and bispecific therapy with Dr. Brian Sworder, MD
- Nitin Jain, MD Challenging case involving advanced B-cell lymphoblastic leukemia (BLL) from the CAR-T and Bispecifics Conference [2024]
Wishing a Happy Birthday to Jeffrey Weber MD today. So important to the field of Immunotherapy. An amazing friend, mentor, leader.
@nyulangone @sitcancer @ASCO @myESMO
VIDEO: CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD https://oncologytube.com/car-t-cell-therapy-in-cll-chronic-lymphocytic-leukemia-navigating-the-landscape-and-looking-ahead-with-catherine-coombs-md/ @UCIrvineHealth @_MDEducation @Ryan_fitzpatric
Oncology Conference Videos
Oncology News
By: Hatem Azim, MD Date. 12/08/2023At SABCS 2023, a discussion on fertility preservation and assisted reproductive…
In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…
Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…
Hamish Scott, MD, serves as the Head of the Department of Genetics and Molecular Pathology…
By: Joyti Bajpai, MD Date: 12/07/2023 In a forthcoming interview, Jyoti Bajpai, MD, a renowned…
Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…
By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…
At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…
Al-Ola Abdallah, MD, Associate Professor of Medicine at The University of Kansas, conducted a study…
In the realm of advancements in CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL),…
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…